Mitral and tricuspid valve intervention : new devices and clinical outcomes

Session comprising selected EuroPCR 2023 Abstract submissions

Facilitators: C. Hammerstingl, T. Modine

Speakers: G. Ascione, A. Duncan, R. Estevez-Loureiro, M. Gröger, V. Ninios, X. Pan, L. Schneider, L. Stolz

Summary

Need a reminder on this session about the new devices and clinical outcomes in mitral and tricuspid valve intervention? Take a look at these slides and review the essential in a glance.

Presentations available when logged in:

TTVR using the EVOQUE system: two-year compassionate use outcome data
Treatment of severe tricuspid regurgitation with novel designed edge-to-edge repair system first-in-man study
Right chambers remodelling after TTVR
TRI-SCORE predicts mortality after transcatheter edge-to-edge tricuspid repair
Three-year outcomes of Tendyne TMVR treating mitral regurgitation: expanded study population
HighLife transseptal mitral valve replacement–first 30 patients one-year follow-up
Transseptal implantation of a TMVR device fixated in the left atrium
Effects of mitral TEER on ventricular arrhythmias in patients with heart failure

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Mitral and tricuspid valve intervention : new devices and clinical outcomes

Session comprising selected EuroPCR 2023 Abstract submissions

Log in or create account for free